OptiBiotix Health PLC (LON:OPTI), the life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, and Agropur Inc. have announced the launch of SlimBiome in the North American market.
The move follows the announcement on 24 June 2019 that OptiBiotix had granted Agropur an exclusive license to manufacture, supply and distribute SlimBiome weight management technology in the USA, Canada and Mexico.
READ: OptiBiotix extends CTC and Cambridge Commodities distribution agreements
Dr. Fred Narbel, managing director of OptiBiotix's prebiotics division, commented: “Over a rather short period of time, Agropur has qualified its manufacturing process and is now able to produce SlimBiome in the USA and supply the ingredient to North American B2B customers."
He added: “This is a key strategic step In OptiBiotix's commercial development as it grants the company access to the US weight management market which was estimated to be worth US$72 billion in 2019.”
Agropur is a wholly-owned subsidiary of Agropur Cooperative, which is a North American dairy industry leader founded in 1938.
With 8,800 employees and sales of US$5.5 billion in 2019, Agropur processes more than 14 billion lbs of milk per year at its 38 plants across North America.
Mike Homewood, vice president of Agropur Custom Solutions, said: “This ingredient solution for weight management fits into Agropur's goal to provide innovative, forward-thinking products to our customers."